Shirley Ryan AbilityLab
sralab.orgTotal trials
174
Active
71
Phase 3
2
Total enrollment
11,049
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 7 of 7 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| 5-Azacitidine | — | — | — | — | — | 2 | |
| Dalfampridine | — | — | — | — | 2 | ||
| Mannitol | — | — | — | — | — | 1 | |
| 5-Azacytidine 10mg/m^2 | — | — | — | — | — | 1 | |
| 5-Azacytidine 20mg/m^2 | — | — | — | — | — | 1 | |
| 5-Azacytidine 35mg/m^2 | — | — | — | — | — | 1 | |
| 5-Azacytidine 75mg/m^2 | — | — | — | — | — | 1 |
Next readouts
- 2026-03
- 2026-12
- 2029-01-01
- 2030-08-31
Top conditions
- Stroke52
- Spinal Cord Injuries24
- Spinal Cord Injury16
- Amputation13
- Multiple Sclerosis8
- Aphasia8
- Cerebral Palsy6
- Healthy6
Frequently asked questions about Shirley Ryan AbilityLab
- How many clinical trials does Shirley Ryan AbilityLab have on ClinicalTrials.gov?
- Shirley Ryan AbilityLab is listed as the lead sponsor on 174 clinical trials in ClinicalTrials.gov, 71 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Shirley Ryan AbilityLab's trials are in Phase 3?
- 2 of Shirley Ryan AbilityLab's trials are in Phase 3, spread across 7 active drug programs.
- What therapeutic areas does Shirley Ryan AbilityLab focus on?
- Shirley Ryan AbilityLab's most-studied conditions on ClinicalTrials.gov are Stroke, Spinal Cord Injuries, Spinal Cord Injury, Amputation, Multiple Sclerosis.
- When are Shirley Ryan AbilityLab's next clinical trial readouts?
- Shirley Ryan AbilityLab has 4 upcoming primary-completion readouts tracked here; the soonest is “Double Dose 4-AP on Functional Recovery After Spinal Cord Injury”, expected around 2026-03.